You are here

Article info

Article menu

Download PDFPDF

XML
Immunotherapy biomarkers
Original research
Prognostic value of novel immune-related genomic biomarkers identified in head and neck squamous cell carcinoma

Authors

  • Yao Yao Department of Head and Neck Surgery, Research Center for Clinical Oncology, Nanjing Medical University Affiliated Cancer Hospital & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, China PubMed articlesGoogle scholar articles
  • Zhongyi Yan Department of Immunology, Key Laboratory of Immune Microenvironment and Disease, Nanjing Medical University, Nanjing, China Jiangsu Key Laboratory of Oral Disease, Nanjing Medical University, Nanjing, China PubMed articlesGoogle scholar articles
  • Senlin Lian Department of Immunology, Key Laboratory of Immune Microenvironment and Disease, Nanjing Medical University, Nanjing, China PubMed articlesGoogle scholar articles
  • Liangnian Wei Department of Immunology, Key Laboratory of Immune Microenvironment and Disease, Nanjing Medical University, Nanjing, China PubMed articlesGoogle scholar articles
  • Chao Zhou Department of Immunology, Key Laboratory of Immune Microenvironment and Disease, Nanjing Medical University, Nanjing, China PubMed articlesGoogle scholar articles
  • Dongju Feng Department of Immunology, Key Laboratory of Immune Microenvironment and Disease, Nanjing Medical University, Nanjing, China PubMed articlesGoogle scholar articles
  • Yuan Zhang Department of Head and Neck Surgery, Research Center for Clinical Oncology, Nanjing Medical University Affiliated Cancer Hospital & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, China PubMed articlesGoogle scholar articles
  • Jianrong Yang Jiangsu Key Laboratory of Oral Disease, Nanjing Medical University, Nanjing, China Department of Oral and Maxillofacial Surgery, Affiliated Hospital of Stomatology, Nanjing Medical University, Nanjing, China PubMed articlesGoogle scholar articles
  • Ming Li Department of Radiation Oncology, Beijing Hospital/National Center of Gerontology, Beijing, China PubMed articlesGoogle scholar articles
  • Yun Chen Department of Head and Neck Surgery, Research Center for Clinical Oncology, Nanjing Medical University Affiliated Cancer Hospital & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, China Department of Immunology, Key Laboratory of Immune Microenvironment and Disease, Nanjing Medical University, Nanjing, China PubMed articlesGoogle scholar articles

Citation

Yao Y, Yan Z, Lian S, et al
Prognostic value of novel immune-related genomic biomarkers identified in head and neck squamous cell carcinoma
Journal for ImmunoTherapy of Cancer 2020;8:e000444. doi: 10.1136/jitc-2019-000444
Online issue publication 
July 27, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.